{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:46:51Z","timestamp":1791312411586,"version":"4.3.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.cytogfr.2005.02.003","type":"journal-article","created":{"date-parts":[[2005,4,2]],"date-time":"2005-04-02T07:15:01Z","timestamp":1112426101000},"page":"205-213","source":"Crossref","is-referenced-by-count":309,"title":["FGF signaling in the developing endochondral skeleton"],"prefix":"10.1016","volume":"16","author":[{"given":"David M.","family":"Ornitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2005.02.003_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1020914026829","article-title":"Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism","volume":"3","author":"Horton","year":"2002","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00210413","article-title":"Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients","volume":"96","author":"Ikegawa","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01954274","article-title":"A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia","volume":"154","author":"Superti-Furga","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng0795-357","article-title":"A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia","volume":"10","author":"Bellus","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1152\/physiolgenomics.2000.2.1.9","article-title":"A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia","volume":"2","author":"Winterpacht","year":"2000","journal-title":"Physiol Genom"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/hmg\/5.4.509","article-title":"Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)","volume":"5","author":"Rousseau","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib9","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/4.11.2175","article-title":"Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I","volume":"4","author":"Tavormina","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib11","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1097\/00006534-200112000-00030","article-title":"From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes","volume":"108","author":"Britto","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib12","series-title":"Craniosynostosis, diagnosis, evaluation and management","first-page":"77","article-title":"Fibroblast growth factor receptor mutations","author":"Cohen","year":"2000"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-9525(00)89088-5","article-title":"Fibroblast-growth-factor receptor mutations in human skeletal disorders","volume":"11","author":"Muenke","year":"1995","journal-title":"Trends Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib14","doi-asserted-by":"crossref","first-page":"D781","DOI":"10.2741\/A321","article-title":"FGF signaling in skeletal development","volume":"3","author":"Naski","year":"1998","journal-title":"Front Biosci"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/0470846658.ch6","article-title":"Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3","volume":"232","author":"Ornitz","year":"2001","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes Develop"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib17","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/6.10.1647","article-title":"Craniosynostosis \u2013 genes and mechanisms","volume":"6","author":"Wilkie","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng0295-165","article-title":"Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome","volume":"9","author":"Wilkie","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ng0896-492","article-title":"Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome","volume":"13","author":"Przylepa","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib20","article-title":"A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome","author":"de Ravel","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/4.8.1387","article-title":"Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome","volume":"4","author":"Gorry","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1194-275","article-title":"Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2","volume":"8","author":"Jabs","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib23","first-page":"491","article-title":"FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing","volume":"58","author":"Meyers","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng1295-462","article-title":"Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans","volume":"11","author":"Meyers","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/hmg\/4.6.1077","article-title":"Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome","volume":"4","author":"Oldridge","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/hmg\/4.7.1229","article-title":"Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability","volume":"4","author":"Park","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0994-98","article-title":"Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome","volume":"8","author":"Reardon","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ng0295-173","article-title":"Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes","volume":"9","author":"Rutland","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/hmg\/4.3.323","article-title":"Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome","volume":"4","author":"Schell","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00214198","article-title":"Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome","volume":"96","author":"Steinberger","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<386::AID-HUMU18>3.0.CO;2-Z","article-title":"Crouzon syndrome: previously unrecognized deletion, duplication, and point mutation within FGFR2 gene","volume":"8","author":"Steinberger","year":"1996","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0960-9822(95)00102-3","article-title":"Functions of fibroblast growth factors and their receptors","volume":"5","author":"Wilkie","year":"1995","journal-title":"Curr Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib33","first-page":"303","article-title":"A new case of Pfeiffer syndrome with mutation in FGFR2","volume":"8","author":"Addor","year":"1997","journal-title":"Genet Counsel"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s004390050979","article-title":"Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome","volume":"104","author":"Cornejo-Roldan","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/(SICI)1096-8628(19980724)78:4<356::AID-AJMG10>3.0.CO;2-H","article-title":"Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III","volume":"78","author":"Gripp","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng0295-108","article-title":"FGFR2 mutations in Pfeiffer syndrome","volume":"9","author":"Lajeunie","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00001665-199805000-00004","article-title":"Pfeiffers-syndrome resulting from an S351c mutation in the fibroblast growth factor receptor-2 gene","volume":"9","author":"Mathijssen","year":"1998","journal-title":"J. Craniofacial Surgery"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ng1096-174","article-title":"Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes","volume":"14","author":"Bellus","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajmg.10775","article-title":"FGFs, their receptors, and human limb malformations: clinical and molecular correlations","volume":"112","author":"Wilkie","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/ddh011","article-title":"Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity","volume":"13","author":"Ibrahimi","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1194-269","article-title":"A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome","volume":"8","author":"Muenke","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00019605-200310000-00012","article-title":"The appearance of the feet in Pfeiffer syndrome caused by FGFR1 P252R mutation","volume":"12","author":"Rossi","year":"2003","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib43","first-page":"76","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","author":"White","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1096-8628(20000703)93:1<22::AID-AJMG5>3.0.CO;2-U","article-title":"Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature","volume":"93","author":"Roscioli","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ng1122","article-title":"Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome","volume":"33","author":"Dode","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib46","first-page":"555","article-title":"A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome","volume":"60","author":"Muenke","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00381-003-0906-y","article-title":"Muenke syndrome","volume":"20","author":"Sabatino","year":"2004","journal-title":"ChildsNerv Syst"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<53::AID-AJMG10>3.0.CO;2-F","article-title":"Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3","volume":"85","author":"Bellus","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1096-8628(19990507)84:1<74::AID-AJMG14>3.0.CO;2-R","article-title":"Let's call it \u201cCrouzonodermoskeletal syndrome\u201d so we won\u2019t be prisoners of our own conventional terminology","volume":"84","author":"Cohen","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.17796\/jcpd.28.2.72m01l5g50448548","article-title":"Crouzonodermoskeletal syndrome","volume":"28","author":"Jeftha","year":"2004","journal-title":"J Clin Pediatr Dent"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1597\/1545-1569(2000)037<0078:CSWANC>2.3.CO;2","article-title":"Crouzon syndrome with acanthosis nigricans: case report and mutational analysis","volume":"37","author":"Nagase","year":"2000","journal-title":"Cleft Palate-Craniofacial J"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib52","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jmg.33.9.744","article-title":"A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans","volume":"33","author":"Wilkes","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib53","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1083\/jcb.102.4.1151","article-title":"Collagen gene expression during limb cartilage differentiation","volume":"102","author":"Kosher","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0174-173X(88)80001-3","article-title":"In situ hybridization analysis of the expression of the type II collagen gene in the developing chicken limb bud","volume":"8","author":"Nah","year":"1988","journal-title":"Coll Relat Res"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/bdrc.10012","article-title":"Morphogenesis and dysmorphogenesis of the appendicular skeleton","volume":"69","author":"Shum","year":"2003","journal-title":"Birth Defects Res Part C, Embryo Today: Rev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0195-15","article-title":"The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos","volume":"9","author":"Wright","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib57","first-page":"107","article-title":"The membranous skeleton: the role of cell condensations invertebrate skeletogenesis","volume":"186","author":"Hall","year":"1992","journal-title":"AnatEmbryol (Berl)"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4","article-title":"All for one and one for all: condensations and the initiation of skeletal development","volume":"22","author":"Hall","year":"2000","journal-title":"Bioessays"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib59","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1083\/jcb.100.2.598","article-title":"Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues","volume":"100","author":"Schmid","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib60","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/jor.1100160416","article-title":"Changes in cell, matrix compartment, and fibrillar collagen volumes between growth-plate zones","volume":"16","author":"Noonan","year":"1998","journal-title":"J Orthop Res"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib61","series-title":"Bone and mineral research","first-page":"117","article-title":"The cellular and molecular embryology of bone formation","author":"Caplan","year":"1987"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","article-title":"Reaching a genetic and molecular understanding of skeletal development","volume":"2","author":"Karsenty","year":"2002","journal-title":"Develop Cell"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature01657","article-title":"Developmental regulation of the growth plate","volume":"423","author":"Kronenberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.cellbio.16.1.191","article-title":"Bone development","volume":"16","author":"Olsen","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0959-437X(00)00228-8","article-title":"Genetic control of skeletal development","volume":"11","author":"Wagner","year":"2001","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1242\/dev.114.1.233","article-title":"Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse","volume":"114","author":"Peters","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","article-title":"Spatio-temporal expression of Fgfr 1, 2 and 3 genes during human embryo-fetal ossification","volume":"77","author":"Delezoide","year":"1998","journal-title":"Mech Dev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib68","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1242\/dev.113.4.1419","article-title":"Developmental expression of two murine fibroblast growth factor receptors, flg and bek","volume":"773","author":"Orr-Urtreger","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib69","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/aja.1002040410","article-title":"Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning","volume":"204","author":"Szebenyi","year":"1995","journal-title":"Dev Dyn"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-0177(199909)216:1<72::AID-DVDY9>3.0.CO;2-9","article-title":"Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene","volume":"216","author":"Colvin","year":"1999","journal-title":"Dev Dyn"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib71","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1242\/dev.118.2.601","article-title":"Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo","volume":"118","author":"deLapeyriere","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/aja.1002030210","article-title":"Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions","volume":"203","author":"Finch","year":"1995","journal-title":"Dev Dyn"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib73","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1242\/dev.112.2.397","article-title":"Expression of the fibroblast growth factor-5 gene in the mouse embryo","volume":"112","author":"Haub","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0925-4773(94)90050-7","article-title":"FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions","volume":"45","author":"Mason","year":"1994","journal-title":"Mech Dev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib75","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/aja.1002020404","article-title":"FGF-2 mRNA and its antisense message are expressed in a developmentally specific manner in the chick limb bud and mesonephros","volume":"202","author":"Savage","year":"1995","journal-title":"Dev Dyn"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib76","first-page":"639","article-title":"Apparent normal phenotype of Fgf6\u2212\/\u2212 mice","volume":"41","author":"Fiore","year":"1997","journal-title":"Int J Devel Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1101\/gad.10.2.165","article-title":"Keratinocyte growth factor is required for hair development but not for wound healing","volume":"10","author":"Guo","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib78","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0092-8674(94)90276-3","article-title":"FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations","volume":"78","author":"Hebert","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib79","first-page":"1113","volume":"97","author":"Murakami","year":"2000","journal-title":"Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib80","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/9.11.1603","article-title":"A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos","volume":"9","author":"Iwata","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib81","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/hmg\/10.12.1255","article-title":"Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice","volume":"10","author":"Iwata","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib82","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/0264-6021:3420677","article-title":"Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro","volume":"342","author":"Weksler","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib83","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","article-title":"Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome","volume":"97","author":"Yu","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib84","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1073\/pnas.081082498","article-title":"Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes","volume":"98","author":"Yu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib85","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/ddh235","article-title":"Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities","volume":"13","author":"Ibrahimi","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib86","doi-asserted-by":"crossref","first-page":"21143","DOI":"10.1074\/jbc.M314323200","article-title":"Statl controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts","volume":"279","author":"Xiao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib87","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib88","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/dbio.1993.1040","article-title":"Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis","volume":"155","author":"Peters","year":"1993","journal-title":"Dev Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib89","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib90","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/0264-6021:3610231","article-title":"The fibroblast growth factor receptor, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs","volume":"361","author":"Pandit","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib91","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0021-9258(18)89567-9","article-title":"Purification of cartilage-derived growth factor by heparin affinity chromatography","volume":"260","author":"Sullivan","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib92","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1016\/S0021-9258(17)37121-1","article-title":"Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells","volume":"269","author":"Hurley","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib93","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1359\/jbmr.1999.14.5.776","article-title":"Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells","volume":"14","author":"Hurley","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib94","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI8641","article-title":"Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation","volume":"105","author":"Montero","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib95","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/en.140.1.434","article-title":"Prostaglandins regulate the expression of fibroblast growth factor-2 in bone","volume":"140","author":"Sabbieti","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib96","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M302113200","article-title":"Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone","author":"Okada","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib97","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1359\/jbmr.1999.14.11.1909","article-title":"Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice","volume":"14","author":"Garofalo","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib98","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.965602","article-title":"Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18","volume":"16","author":"Liu","year":"2002","journal-title":"Genes Develop"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib99","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1101\/gad.965702","article-title":"FGF 18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis","volume":"16","author":"Ohbayashi","year":"2002","journal-title":"Genes Develop"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0925-4773(99)00034-9","article-title":"Genomic structure, mapping, activity and expression of fibroblast growth factor 17","volume":"83","author":"Xu","year":"1999","journal-title":"Mech Dev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib101","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng0298-136","article-title":"An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination","volume":"18","author":"Meyers","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib102","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1242\/dev.127.9.1833","article-title":"Temporal and spatial gradients of Fgf8 and Fgfl7 regulate proliferation and differentiation of midline cerebellar structures","volume":"127","author":"Xu","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib103","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib104","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/hmg\/10.5.457","article-title":"A Ser(365)->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh\/PTHrP signals and causes severe achondroplasia","volume":"10","author":"Chen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib106","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib107","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","article-title":"A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation","volume":"161","author":"Dailey","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib108","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1359\/jbmr.2000.15.1.155","article-title":"Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells","volume":"15","author":"Henderson","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib109","doi-asserted-by":"crossref","unstructured":"Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, A., Y. Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J Cell Sci 2002;115:553\u201362.","DOI":"10.1242\/jcs.115.3.553"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1534-5807(02)00261-7","article-title":"Interaction of FGF, Ihh\/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation","volume":"3","author":"Minina","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib111","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/joca.2002.0514","article-title":"Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors","volume":"10","author":"Ellsworth","year":"2002","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib112","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1523\/JNEUROSCI.16-15-04579.1996","article-title":"The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC 12 cells by aFGF","volume":"16","author":"Lin","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib113","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib114","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/MCB.14.1.181","article-title":"Fibroblast growth factor receptors have different signaling and mitogenic potentials","volume":"14","author":"Wang","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib115","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1242\/dev.128.19.3867","article-title":"Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains","volume":"128","author":"Wang","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib116","first-page":"7178","volume":"96","author":"Raffioni","year":"1999","journal-title":"Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC 12 cells"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib117","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.M310384200","article-title":"Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes","volume":"279","author":"Raucci","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib118","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib119","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Statl, Stat5 and p21Cipl correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib121","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib122","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib123","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","article-title":"Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia","volume":"273","author":"Legeai-Mallet","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib124","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1242\/dev.128.11.2119","article-title":"STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2","volume":"128","author":"Sahni","year":"2001","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.cytogfr.2005.02.003_bib125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000074503","article-title":"Molecular basis for the treatment of achondroplasia","volume":"60","author":"Yamanaka","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib126","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","article-title":"The IIIc alternative of Fgfr2 is a positive regulator of bone formation","volume":"129","author":"Eswarakumar","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib127","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1242\/dev.00491","article-title":"Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth","volume":"130","author":"Yu","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2005.02.003_bib128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/ddh034","article-title":"Defective bone mineralization and osteopenia in young adult FGFR3\u2212\/\u2212 mice","volume":"13","author":"Valverde-Franco","year":"2004","journal-title":"Hum Mol Genet"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610105000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610105000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T16:58:11Z","timestamp":1625677091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610105000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1359610105000109"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2005.02.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}